ASLTY (Asymchem Laboratories Tianjin Co) Cyclically Adjusted Revenue per Share: $0.62 (As of Mar. 2026)


ASLTY Asymchem Laboratories Tianjin Co Ltd ASLTY
69 GF Score
Price $6.37
GF Value $3.90
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co Cyclically Adjusted Revenue per Share?

Asymchem Laboratories Tianjin Co ASLTY 69 Cyclically Adjusted Revenue per Share is $0.62 as of Mar. 2026. GuruFocus rates ASLTY with a GF Score™ of 69/100 and a GF Value™ of $3.90 (Significantly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Asymchem Laboratories Tianjin Co's adjusted revenue per share for the three months ended in Mar. 2026 was $0.361. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.62 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Asymchem Laboratories Tianjin Co's average Cyclically Adjusted Revenue Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-01), Asymchem Laboratories Tianjin Co's current stock price is $6.37. Asymchem Laboratories Tianjin Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.62. Asymchem Laboratories Tianjin Co's Cyclically Adjusted PS Ratio of today is 10.27.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Asymchem Laboratories Tianjin Co was 11.94. The lowest was 5.07. And the median was 7.20.


Asymchem Laboratories Tianjin Co  (OTCPK:ASLTY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Asymchem Laboratories Tianjin Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.37/0.62
=10.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Asymchem Laboratories Tianjin Co was 11.94. The lowest was 5.07. And the median was 7.20.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Asymchem Laboratories Tianjin Co Cyclically Adjusted Revenue per Share Related Terms


Asymchem Laboratories Tianjin Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Asymchem Laboratories Tianjin Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asymchem Laboratories Tianjin Co Cyclically Adjusted Revenue per Share Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.51 0.46

Asymchem Laboratories Tianjin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.45 0.36 0.46 0.62

ASLTY vs VRTX, REGN, ALNY: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's Cyclically Adjusted PS Ratio falls into.


ASLTY
69GF Score
Asymchem Laboratories Tianjin Co Ltd ASLTY
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asymchem Laboratories Tianjin Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Asymchem Laboratories Tianjin Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.361/116.3033*116.3033
=0.361

Current CPI (Mar. 2026) = 116.3033.

Asymchem Laboratories Tianjin Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.089 101.400 0.102
201609 0.093 102.400 0.106
201612 0.085 102.600 0.096
201703 0.067 103.200 0.076
201706 0.059 103.100 0.067
201709 0.081 104.100 0.090
201712 0.123 104.500 0.137
201803 0.091 105.300 0.101
201806 0.078 104.900 0.086
201809 0.105 106.600 0.115
201812 0.142 106.500 0.155
201903 0.110 107.700 0.119
201906 0.137 107.700 0.148
201909 0.143 109.800 0.151
201912 0.158 111.200 0.165
202003 0.105 112.300 0.109
202006 0.170 110.400 0.179
202009 0.184 111.700 0.192
202012 0.238 111.500 0.248
202103 0.177 112.662 0.183
202106 0.124 111.769 0.129
202109 0.372 112.215 0.386
202112 0.394 113.108 0.405
202203 0.442 114.335 0.450
202206 0.606 114.558 0.615
202209 0.542 115.339 0.547
202212 0.474 115.116 0.479
202303 0.445 115.116 0.450
202306 0.462 114.558 0.469
202309 0.334 115.339 0.337
202312 0.278 114.781 0.282
202403 0.262 115.227 0.264
202406 0.261 114.781 0.264
202409 0.294 115.785 0.295
202412 0.326 114.893 0.330
202503 0.290 115.116 0.293
202506 0.312 114.907 0.316
202509 0.276 115.471 0.278
202512 0.436 115.832 0.438
202603 0.361 116.303 0.361

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.62 mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a Cyclically Adjusted Revenue per Share of $0.62 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Asymchem Laboratories Tianjin Co and its competitors.
Is Asymchem Laboratories Tianjin Co's Cyclically Adjusted Revenue per Share too high?
Asymchem Laboratories Tianjin Co's current Cyclically Adjusted Revenue per Share is $0.62. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Asymchem Laboratories Tianjin Co's Cyclically Adjusted Revenue per Share of $0.62 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Asymchem Laboratories Tianjin Co and its competitors. Asymchem Laboratories Tianjin Co's current Cyclically Adjusted Revenue per Share is $0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.90, compared to a current price of $6.37 — trading 63.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.62. Asymchem Laboratories Tianjin Co's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current Cyclically Adjusted Revenue per Share is $0.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of $6.37 is trading 63.3% above its estimated GF Value™ of $3.90. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for ASLTY:

  • Cyclically Adjusted Revenue per Share: $0.62
  • GF Value™: $3.90 vs. price of $6.37 (63.3% above fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Asymchem Laboratories Tianjin Co Business Description

Other Exchanges 06821:Hong Kong002821:China
Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
69GF Score

Get the complete analysis for ASLTY

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.37
Price
$3.90
GF Value